NEW YORK (GenomeWeb) – Edico Genome said today that it raised $10 million in a Series A round of financing that it will use to commercialize its Dragen Bio-IT Processor, an application-specific integrated circuit system for next-generation sequence data analysis.

The financing round was led by Qualcomm through its venture investment group Qualcomm Ventures. The list of investors includes Axon Ventures and Greg Lucier, former Life Technologies chairman and CEO. As part of his investment, Lucier has joined Edico Genome's board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.